Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

REX vs GPRE vs ANDE vs BIOX vs ADM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
REX
REX American Resources Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$1.60B
5Y Perf.+398.3%
GPRE
Green Plains Inc.

Chemicals - Specialty

Basic MaterialsNASDAQ • US
Market Cap$1.15B
5Y Perf.+92.5%
ANDE
The Andersons, Inc.

Food Distribution

Consumer DefensiveNASDAQ • US
Market Cap$2.41B
5Y Perf.+446.4%
BIOX
Bioceres Crop Solutions Corp.

Agricultural Inputs

Basic MaterialsNASDAQ • AR
Market Cap$30M
5Y Perf.-92.9%
ADM
Archer-Daniels-Midland Company

Agricultural Farm Products

Consumer DefensiveNYSE • US
Market Cap$37.36B
5Y Perf.+97.2%

REX vs GPRE vs ANDE vs BIOX vs ADM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
REX logoREX
GPRE logoGPRE
ANDE logoANDE
BIOX logoBIOX
ADM logoADM
IndustryChemicals - SpecialtyChemicals - SpecialtyFood DistributionAgricultural InputsAgricultural Farm Products
Market Cap$1.60B$1.15B$2.41B$30M$37.36B
Revenue (TTM)$651M$1.94B$10.98B$318M$80.61B
Net Income (TTM)$50M$-15M$129M$-53M$1.08B
Gross Margin12.7%1.8%6.6%39.1%5.8%
Operating Margin8.6%1.2%1.1%0.2%1.5%
Forward P/E62.8x46.6x14.5x18.6x
Total Debt$21M$508M$1.04B$277M$8.41B
Cash & Equiv.$196M$182M$98M$33M$1.01B

REX vs GPRE vs ANDE vs BIOX vs ADMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

REX
GPRE
ANDE
BIOX
ADM
StockMay 20May 26Return
REX American Resour… (REX)100498.3+398.3%
Green Plains Inc. (GPRE)100192.5+92.5%
The Andersons, Inc. (ANDE)100546.4+446.4%
Bioceres Crop Solut… (BIOX)1007.1-92.9%
Archer-Daniels-Midl… (ADM)100197.2+97.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: REX vs GPRE vs ANDE vs BIOX vs ADM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: REX and ANDE are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. The Andersons, Inc. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. ADM and GPRE also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
REX
REX American Resources Corporation
The Long-Run Compounder

REX has the current edge in this matchup, primarily because of its strength in long-term compounding.

  • 464.7% 10Y total return vs ANDE's 192.1%
  • 7.7% margin vs BIOX's -16.6%
  • 6.7% ROA vs BIOX's -6.7%, ROIC 11.4% vs -0.5%
Best for: long-term compounding
GPRE
Green Plains Inc.
The Momentum Pick

GPRE is the clearest fit if your priority is momentum.

  • +336.6% vs BIOX's -88.5%
Best for: momentum
ANDE
The Andersons, Inc.
The Growth Play

ANDE is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.

  • Rev growth -2.2%, EPS growth -15.7%, 3Y rev CAGR -14.0%
  • PEG 0.22 vs REX's 1.18
  • -2.2% revenue growth vs BIOX's -28.3%
  • Lower P/E (14.5x vs 18.6x)
Best for: growth exposure and valuation efficiency
BIOX
Bioceres Crop Solutions Corp.
The Basic Materials Pick

Among these 5 stocks, BIOX doesn't own a clear edge in any measured category.

Best for: basic materials exposure
ADM
Archer-Daniels-Midland Company
The Income Pick

ADM ranks third and is worth considering specifically for income & stability and sleep-well-at-night.

  • Dividend streak 31 yrs, beta 0.12, yield 2.6%
  • Lower volatility, beta 0.12, Low D/E 36.5%, current ratio 11.20x
  • Beta 0.12, yield 2.6%, current ratio 11.20x
  • Beta 0.12 vs BIOX's 1.94, lower leverage
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthANDE logoANDE-2.2% revenue growth vs BIOX's -28.3%
ValueANDE logoANDELower P/E (14.5x vs 18.6x)
Quality / MarginsREX logoREX7.7% margin vs BIOX's -16.6%
Stability / SafetyADM logoADMBeta 0.12 vs BIOX's 1.94, lower leverage
DividendsADM logoADM2.6% yield, 31-year raise streak, vs ANDE's 1.1%, (3 stocks pay no dividend)
Momentum (1Y)GPRE logoGPRE+336.6% vs BIOX's -88.5%
Efficiency (ROA)REX logoREX6.7% ROA vs BIOX's -6.7%, ROIC 11.4% vs -0.5%

REX vs GPRE vs ANDE vs BIOX vs ADM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

REXREX American Resources Corporation
FY 2024
Other Member
100.0%$329,000
GPREGreen Plains Inc.
FY 2025
Products And Services Other
101.2%$94M
Intersegment Revenues
-1.2%$-1,119,000
ANDEThe Andersons, Inc.
FY 2025
Agribusiness Segment
75.0%$8.3B
Renewables
25.0%$2.7B
BIOXBioceres Crop Solutions Corp.

Segment breakdown not available.

ADMArcher-Daniels-Midland Company
FY 2025
Ag Services and Oilseeds
77.1%$61.6B
Carbohydrate Solutions
13.5%$10.7B
Nutrition
9.4%$7.5B

REX vs GPRE vs ANDE vs BIOX vs ADM — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLREXLAGGINGBIOX

Income & Cash Flow (Last 12 Months)

Evenly matched — REX and BIOX each lead in 2 of 6 comparable metrics.

ADM is the larger business by revenue, generating $80.6B annually — 253.3x BIOX's $318M. REX is the more profitable business, keeping 7.7% of every revenue dollar as net income compared to BIOX's -16.6%. On growth, ADM holds the edge at +1.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricREX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.ANDE logoANDEThe Andersons, In…BIOX logoBIOXBioceres Crop Sol…ADM logoADMArcher-Daniels-Mi…
RevenueTrailing 12 months$651M$1.9B$11.0B$318M$80.6B
EBITDAEarnings before interest/tax$67M$122M$218M$21M$3.0B
Net IncomeAfter-tax profit$50M-$15M$129M-$53M$1.1B
Free Cash FlowCash after capex$18M$90M-$105M$37M$4.8B
Gross MarginGross profit ÷ Revenue+12.7%+1.8%+6.6%+39.1%+5.8%
Operating MarginEBIT ÷ Revenue+8.6%+1.2%+1.1%+0.2%+1.5%
Net MarginNet income ÷ Revenue+7.7%-0.8%+1.2%-16.6%+1.3%
FCF MarginFCF ÷ Revenue+2.7%+4.7%-1.0%+11.5%+6.0%
Rev. Growth (YoY)Latest quarter vs prior year+0.4%-25.9%-1.2%-16.4%+1.6%
EPS Growth (YoY)Latest quarter vs prior year+2.9%+134.2%+96.0%-37.3%+1.6%
Evenly matched — REX and BIOX each lead in 2 of 6 comparable metrics.

Valuation Metrics

Evenly matched — ANDE and BIOX each lead in 3 of 7 comparable metrics.

At 25.3x trailing earnings, ANDE trades at a 27% valuation discount to ADM's 34.8x P/E. Adjusting for growth (PEG ratio), ANDE offers better value at 0.39x vs REX's 0.55x — a lower PEG means you pay less per unit of expected earnings growth.

MetricREX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.ANDE logoANDEThe Andersons, In…BIOX logoBIOXBioceres Crop Sol…ADM logoADMArcher-Daniels-Mi…
Market CapShares × price$1.6B$1.1B$2.4B$30M$37.4B
Enterprise ValueMkt cap + debt − cash$1.4B$1.5B$3.4B$274M$44.8B
Trailing P/EPrice ÷ TTM EPS29.50x-9.14x25.29x-0.58x34.77x
Forward P/EPrice ÷ next-FY EPS est.62.81x46.62x14.50x18.63x
PEG RatioP/E ÷ EPS growth rate0.55x0.39x
EV / EBITDAEnterprise value multiple16.60x103.82x12.82x20.01x17.18x
Price / SalesMarket cap ÷ Revenue2.50x0.55x0.22x0.09x0.47x
Price / BookPrice ÷ Book value/share2.67x1.44x1.88x0.10x1.63x
Price / FCFMarket cap ÷ FCF17.84x0.85x8.89x
Evenly matched — ANDE and BIOX each lead in 3 of 7 comparable metrics.

Profitability & Efficiency

REX leads this category, winning 6 of 9 comparable metrics.

ANDE delivers a 9.5% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-17 for BIOX. REX carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to BIOX's 0.94x. On the Piotroski fundamental quality scale (0–9), ANDE scores 6/9 vs BIOX's 3/9, reflecting solid financial health.

MetricREX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.ANDE logoANDEThe Andersons, In…BIOX logoBIOXBioceres Crop Sol…ADM logoADMArcher-Daniels-Mi…
ROE (TTM)Return on equity+7.7%-2.0%+9.5%-16.7%+4.7%
ROA (TTM)Return on assets+6.7%-1.0%+3.6%-6.7%+2.2%
ROICReturn on invested capital+11.4%-5.2%+4.6%-0.5%+3.3%
ROCEReturn on capital employed+10.1%-6.2%+5.8%-0.8%+4.2%
Piotroski ScoreFundamental quality 0–954636
Debt / EquityFinancial leverage0.03x0.66x0.81x0.94x0.37x
Net DebtTotal debt minus cash-$175M$326M$945M$244M$7.4B
Cash & Equiv.Liquid assets$196M$182M$98M$33M$1.0B
Total DebtShort + long-term debt$21M$508M$1.0B$277M$8.4B
Interest CoverageEBIT ÷ Interest expense-0.08x3.21x-0.07x3.03x
REX leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

REX leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in REX five years ago would be worth $34,996 today (with dividends reinvested), compared to $317 for BIOX. Over the past 12 months, GPRE leads with a +336.6% total return vs BIOX's -88.5%. The 3-year compound annual growth rate (CAGR) favors REX at 50.8% vs BIOX's -64.0% — a key indicator of consistent wealth creation.

MetricREX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.ANDE logoANDEThe Andersons, In…BIOX logoBIOXBioceres Crop Sol…ADM logoADMArcher-Daniels-Mi…
YTD ReturnYear-to-date+50.2%+60.1%+34.2%-65.0%+32.2%
1-Year ReturnPast 12 months+147.6%+336.6%+127.2%-88.5%+66.2%
3-Year ReturnCumulative with dividends+243.1%-46.8%+97.0%-95.3%+10.7%
5-Year ReturnCumulative with dividends+250.0%-48.5%+141.6%-96.8%+29.2%
10-Year ReturnCumulative with dividends+464.7%+21.3%+192.1%-95.1%+147.4%
CAGR (3Y)Annualised 3-year return+50.8%-19.0%+25.4%-64.0%+3.4%
REX leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

ADM leads this category, winning 2 of 2 comparable metrics.

ADM is the less volatile stock with a 0.12 beta — it tends to amplify market swings less than BIOX's 1.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ADM currently trades 94.8% from its 52-week high vs BIOX's 9.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricREX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.ANDE logoANDEThe Andersons, In…BIOX logoBIOXBioceres Crop Sol…ADM logoADMArcher-Daniels-Mi…
Beta (5Y)Sensitivity to S&P 5000.36x1.22x0.55x1.94x0.12x
52-Week HighHighest price in past year$53.36$18.94$82.11$5.18$81.75
52-Week LowLowest price in past year$19.44$3.39$31.03$0.35$46.81
% of 52W HighCurrent price vs 52-week peak+91.2%+86.9%+86.2%+9.1%+94.8%
RSI (14)Momentum oscillator 0–10059.154.335.044.668.4
Avg Volume (50D)Average daily shares traded204K1.5M333K804K3.8M
ADM leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

ADM leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: REX as "Buy", GPRE as "Buy", ANDE as "Buy", ADM as "Hold". Consensus price targets imply 23.3% upside for REX (target: $60) vs -22.6% for ADM (target: $60). For income investors, ADM offers the higher dividend yield at 2.63% vs ANDE's 1.11%.

MetricREX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.ANDE logoANDEThe Andersons, In…BIOX logoBIOXBioceres Crop Sol…ADM logoADMArcher-Daniels-Mi…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHold
Price TargetConsensus 12-month target$60.00$13.80$75.00$60.00
# AnalystsCovering analysts3202036
Dividend YieldAnnual dividend ÷ price+1.1%+2.6%
Dividend StreakConsecutive years of raises02331
Dividend / ShareAnnual DPS$0.79$2.04
Buyback YieldShare repurchases ÷ mkt cap+0.9%+2.6%+0.6%+3.1%0.0%
ADM leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

REX leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). ADM leads in 2 (Risk & Volatility, Analyst Outlook). 2 tied.

Best OverallREX American Resources Corp… (REX)Leads 2 of 6 categories
Loading custom metrics...

REX vs GPRE vs ANDE vs BIOX vs ADM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is REX or GPRE or ANDE or BIOX or ADM a better buy right now?

For growth investors, The Andersons, Inc.

(ANDE) is the stronger pick with -2. 2% revenue growth year-over-year, versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). The Andersons, Inc. (ANDE) offers the better valuation at 25. 3x trailing P/E (14. 5x forward), making it the more compelling value choice. Analysts rate REX American Resources Corporation (REX) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — REX or GPRE or ANDE or BIOX or ADM?

On trailing P/E, The Andersons, Inc.

(ANDE) is the cheapest at 25. 3x versus Archer-Daniels-Midland Company at 34. 8x. On forward P/E, The Andersons, Inc. is actually cheaper at 14. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Andersons, Inc. wins at 0. 22x versus REX American Resources Corporation's 1. 18x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — REX or GPRE or ANDE or BIOX or ADM?

Over the past 5 years, REX American Resources Corporation (REX) delivered a total return of +250.

0%, compared to -96. 8% for Bioceres Crop Solutions Corp. (BIOX). Over 10 years, the gap is even starker: REX returned +464. 7% versus BIOX's -95. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — REX or GPRE or ANDE or BIOX or ADM?

By beta (market sensitivity over 5 years), Archer-Daniels-Midland Company (ADM) is the lower-risk stock at 0.

12β versus Bioceres Crop Solutions Corp. 's 1. 94β — meaning BIOX is approximately 1584% more volatile than ADM relative to the S&P 500. On balance sheet safety, REX American Resources Corporation (REX) carries a lower debt/equity ratio of 3% versus 94% for Bioceres Crop Solutions Corp. — giving it more financial flexibility in a downturn.

05

Which is growing faster — REX or GPRE or ANDE or BIOX or ADM?

By revenue growth (latest reported year), The Andersons, Inc.

(ANDE) is pulling ahead at -2. 2% versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). On earnings-per-share growth, the picture is similar: REX American Resources Corporation grew EPS -4. 9% year-over-year, compared to -1704. 7% for Bioceres Crop Solutions Corp.. Over a 3-year CAGR, BIOX leads at 0. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — REX or GPRE or ANDE or BIOX or ADM?

REX American Resources Corporation (REX) is the more profitable company, earning 9.

1% net margin versus -15. 5% for Bioceres Crop Solutions Corp. — meaning it keeps 9. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: REX leads at 10. 0% versus -4. 0% for GPRE. At the gross margin level — before operating expenses — BIOX leads at 39. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is REX or GPRE or ANDE or BIOX or ADM more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, The Andersons, Inc. (ANDE) is the more undervalued stock at a PEG of 0. 22x versus REX American Resources Corporation's 1. 18x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Andersons, Inc. (ANDE) trades at 14. 5x forward P/E versus 62. 8x for REX American Resources Corporation — 48. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for REX: 23. 3% to $60. 00.

08

Which pays a better dividend — REX or GPRE or ANDE or BIOX or ADM?

In this comparison, ADM (2.

6% yield), ANDE (1. 1% yield) pay a dividend. REX, GPRE, BIOX do not pay a meaningful dividend and should not be held primarily for income.

09

Is REX or GPRE or ANDE or BIOX or ADM better for a retirement portfolio?

For long-horizon retirement investors, Archer-Daniels-Midland Company (ADM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

12), 2. 6% yield, +147. 4% 10Y return). Bioceres Crop Solutions Corp. (BIOX) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ADM: +147. 4%, BIOX: -95. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between REX and GPRE and ANDE and BIOX and ADM?

These companies operate in different sectors (REX (Basic Materials) and GPRE (Basic Materials) and ANDE (Consumer Defensive) and BIOX (Basic Materials) and ADM (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

ANDE, ADM pay a dividend while REX, GPRE, BIOX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

REX

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

GPRE

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
Run This Screen
Stocks Like

ANDE

Stable Dividend Mega-Cap

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

BIOX

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
  • Gross Margin > 23%
Run This Screen
Stocks Like

ADM

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Dividend Yield > 1.0%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform REX and GPRE and ANDE and BIOX and ADM on the metrics below

Revenue Growth>
%
(REX: 0.4% · GPRE: -25.9%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.